2245020-50-0
Chemical Structure
AB-506
- CAS No.: 2245020-50-0
- Formula:C21H18ClF2N5O3
- Molecular Weight:461.85
IUPAC Name: (1-methyl-1H-1,2,4-triazol-3-yl)methyl (S)-(4-((3-chloro-4-fluorophenyl)carbamoyl)-7-fluoro-2,3-dihydro-1H-inden-1-yl)carbamate
InChIKey: DMJDVZSGLNPLSS-KRWDZBQOSA-N
SMILES: ClC(C=C1NC(C2=C3C([C@H](CC3)NC(OCC4=NN(C)C=N4)=O)=C(C=C2)F)=O)=C(C=C1)F
Biological Activity: AB-506 is an orally active inhibitor of HBV replication targeting the viral core protein. AB-506 can bind to HBV core protein, accelerate capsid assembly and inhibit HBV pgRNA encapsidation. AB-506 can be used in chronic hepatitis B (CHB) research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AB-506 | AB-506 is an orally active inhibitor of HBV replication targeting the viral core protein. AB-506 can bind to HBV core protein, accelerate capsid assembly and inhibit HBV pgRNA encapsidation. AB-506 can be used in chronic hepatitis B (CHB) research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
